$67.71
0.19% day before yesterday
NYSE, May 30, 10:10 pm CET
ISIN
US4050241003
Symbol
HAE

Haemonetics Corporation Stock price

$67.71
+4.69 7.44% 1M
-19.77 22.60% 6M
-10.37 13.28% YTD
-16.94 20.01% 1Y
+3.55 5.53% 3Y
-42.17 38.38% 5Y
+25.82 61.64% 10Y
NYSE, Closing price Fri, May 30 2025
-0.13 0.19%
ISIN
US4050241003
Symbol
HAE
Sector

Key metrics

Market capitalization $3.25b
Enterprise Value $4.17b
P/E (TTM) P/E ratio 20.03
EV/FCF (TTM) EV/FCF 34.37
EV/Sales (TTM) EV/Sales 3.06
P/S ratio (TTM) P/S ratio 2.39
P/B ratio (TTM) P/B ratio 3.98
Revenue growth (TTM) Revenue growth 3.96%
Revenue (TTM) Revenue $1.36b
EBIT (operating result TTM) EBIT $235.61m
Free Cash Flow (TTM) Free Cash Flow $121.34m
Cash position $306.76m
EPS (TTM) EPS $3.38
P/E forward 18.11
P/S forward 2.50
EV/Sales forward 3.20
Short interest 13.87%
Show more

Is Haemonetics Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Haemonetics Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Haemonetics Corporation forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Haemonetics Corporation forecast:

Buy
90%
Hold
10%

Financial data from Haemonetics Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,361 1,361
4% 4%
100%
- Direct Costs 601 601
1% 1%
44%
760 760
8% 8%
56%
- Selling and Administrative Expenses 411 411
0% 0%
30%
- Research and Development Expense 63 63
16% 16%
5%
284 284
20% 20%
21%
- Depreciation and Amortization 48 48
51% 51%
4%
EBIT (Operating Income) EBIT 236 236
16% 16%
17%
Net Profit 168 168
43% 43%
12%

In millions USD.

Don't miss a Thing! We will send you all news about Haemonetics Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Haemonetics Corporation Stock News

Neutral
PRNewsWire
2 days ago
BOSTON , May 30, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025 at 8:40 a.m. ET. The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following l...
Neutral
Seeking Alpha
22 days ago
Haemonetics Corporation (NYSE:HAE ) Q4 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Olga Guyette – Vice President-Investor Relations & Treasury Chris Simon – Chief Executive Officer James D'Arecca – Chief Financial Officer Conference Call Participants Rohin Patel – JPMorgan Marie Thibault – BTIG Mike Matson – Needham & Company Andrew Cooper – Raymond James Joanne Wu...
Neutral
PRNewsWire
24 days ago
Financial release accessible online BOSTON , May 8, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2025, which ended March 29, 2025, are available on its Investor Relations website. The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at ...
More Haemonetics Corporation News

Company Profile

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following geographical segments: Japan, EMEA (Europe, the Middle East, and Africa), North America Plasma, and All Other. Its products include surgical and diagnostic devices, blood and plasma center devices, blood center software, hospital software, and plasma center software. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Braintree, MA.

Head office United States
CEO Christopher Simon
Employees 3,657
Founded 1971
Website www.haemonetics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today